Company news

Profound Medical Corp news in 2026

Profound Medical Corp's news releases, calls and decks from 2026, newest first.

View company

Profound Medical Reports Strong Third Quarter 2026 Results; Expands U.S. Distribution and Positions Leadership for Next Phase of Growth

November 5, 2026

Profound Medical and Cook Medical's iMRI Division Partner to Expand U.S. TULSA-PRO® Sales Channels and Drive Recurring Revenue Growth

October 30, 2026

Emmy-Award Winning Television Host Montel Williams to Join Next 'Let's Huddle' Webinar

October 22, 2026

TULSA Abstracts at the 15th Interventional MRI Symposium Strengthen Real-World Evidence, Clinical Differentiation, and Platform Expansion Opportunity

October 14, 2026

Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care

October 9, 2026

Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue

October 7, 2026

Profound Medical to Participate in Lake Street’s 10th Annual Best Ideas Growth Conference

September 3, 2026

Profound Medical Further Strengthens Executive Leadership Team with Appointment of Richard Fabian as President

September 1, 2026

Profound’s Introduction of New Real-time Interventional MRI Software Paving the Way for Full ‘TULSA Days’

August 17, 2026

Profound Medical Announces Management Change

August 14, 2026

Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey

August 13, 2026

Profound Medical Reports Second Quarter 2026 Financial Results

August 6, 2026

Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial

July 24, 2026

Profound Medical to Release Second Quarter 2026 Financial Results on August 6th - Conference Call to Follow

July 16, 2026

Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026

July 15, 2026

Profound to Showcase TULSA-PRO®, the TULSA Procedure(TM) and the Future of iMRI at AUA2026

May 14, 2026

Profound Medical Reports Strong First Quarter 2026 Financial Results

May 7, 2026

Profound Medical to Release First Quarter 2026 Financial Results on May 7 Conference Call to Follow

April 17, 2026

Profound Medical to Release First Quarter 2026 Financial Results on May 7 - Conference Call to Follow

April 16, 2026

Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference

April 14, 2026

Incision-Free, MRI-Guided Prostate Treatment with Profound's TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting

April 1, 2026

Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure(TM) Milestone

March 27, 2026

CAPTAIN Trial Comparing Profound’s MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence

March 13, 2026

Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24

March 9, 2026

Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results

March 5, 2026

Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th Conference Call to Follow

February 13, 2026

Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow

February 12, 2026

Profound Medical Honored with INOVAIT’s 2025–2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease

February 12, 2026

PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women's Health

February 5, 2026

Profound Medical Announces Upcoming Investor Events

January 27, 2026

Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®

January 15, 2026

Profound Surpasses 2025 TULSA-PRO® Installed Base Goal

January 12, 2026

Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case

January 6, 2026

Calls in 2026

Decks in 2026